Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
| Autor: | Kurzrock, R. *, Gurski, L.A., Carlson, R.W., Ettinger, D.S., Horwitz, S.M., Kumar, S.K., Million, L., von Mehren, M., Benson, A.B., III |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30(10):1647-1652 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|